Colgate-Palmolive
2,038 hedge funds and large institutions have $62B invested in Colgate-Palmolive in 2026 Q2 according to their latest regulatory filings, with 189 funds opening new positions, 735 increasing their positions, 740 reducing their positions, and 105 closing their positions.
80% more first-time investments, than exits
New positions opened: 189 | Existing positions closed: 105
43% more call options, than puts
Call options by funds: $451M | Put options by funds: $314M
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
3% more funds holding
Funds holding: 1,978 → 2,038 (+60)
9% more capital inflows, than outflows
Capital inflows: $4.19B | Capital outflows: $3.85B
0.63% more ownership
Funds ownership: 83.93% → 84.55% (+0.63%)
1% less repeat investments, than reductions
Existing positions increased: 735 | Existing positions reduced: 740
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$546M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$253M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$122M |
| 4 |
Morgan Stanley
New York
|
+$104M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$101M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$509M |
| 2 |
BlackRock
New York
|
-$239M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$155M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$153M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$142M |
CL Hedge Fund Activity: Q2 2026 in Review
2,038 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q2 2026, worth a combined $62B — up 8.1% from $57.4B a quarter earlier.
Buyers outnumbered sellers: 189 funds opened new CL positions and 105 closed out — a net gain of 84 holders — while 735 added to existing stakes and 740 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $546M. The largest seller was T. Rowe Price Associates, cutting an estimated $509M.
- 2,038 institutional investors held Colgate-Palmolive (CL) as of Q2 2026, up from 1,978 in Q1 2026.
- Funds reported $62B of Colgate-Palmolive stock for Q2 2026, up 8.1% quarter-over-quarter.
- 189 funds opened new Colgate-Palmolive positions in Q2 2026 and 105 closed out, a net change of +84 holders.
- The largest Colgate-Palmolive buyer in Q2 2026 was Royal Bank of Canada, an estimated $546M added.
- The largest Colgate-Palmolive seller in Q2 2026 was T. Rowe Price Associates, an estimated $509M sold.
Based on aggregated 13F filings for Q2 2026.